Later scan images to better see bladder cancer spread
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether taking extra, later images during your standard FDG PET-CT scan can give doctors a better view of how far your muscle-invasive bladder cancer has spread. You may be eligible if you are 18 or older, have confirmed muscle-invasive bladder cancer, and are already getting this type of scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have muscle-invasive bladder cancer (stage pT2 or higher) confirmed by a biopsy.
- You are already scheduled for an FDG PET-CT scan at Hôpital Foch.
- You have not had another pelvic or genitourinary cancer before.
- Your bladder cancer has not been found to have spread beyond the bladder (metastatic disease).
- You are not pregnant or breastfeeding, and you can safely have a PET-CT scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study checks whether an FDG PET-CT scan can help doctors better predict bladder cancer risk and adjust treatment. You may still get standard bladder cancer care, but the study uses the scan results to help decide how aggressive treatment should be.
This study tests a new type of PET scan dye to see how well it shows bladder tumors. It may help doctors get clearer images without needing extra biopsies.
This study uses a special PET/CT scan to see how far your bladder cancer has spread. The results may help doctors plan the best treatment for you.
This trial studies a special PET/CT scan tracer that is designed to bind to a protein (Nectin-4) found in some bladder cancers. It aims to help doctors see and stage tumors more clearly, which could improve diagnosis and treatment planning.
This trial is testing if two types of PET/MRI scans (one using FAPI tracer, another using FDG tracer) are better at finding and evaluating muscle-invasive bladder cancer. It may help doctors decide the best treatment for you.
This study tests a new type of PET scan (a special imaging test) called 18F-FGIn to help doctors better detect and evaluate cancers. It may be more accurate than the standard PET scan for certain tumors like brain, liver, stomach, and colon cancers.
Hear when a new Muscle-Invasive Bladder Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.